Ontology highlight
ABSTRACT: Importance
Older adults are often excluded from clinical trials. The benefit of preventive interventions tested in younger trial populations may be reduced when applied to older adults in the clinical setting if they are less likely to survive long enough to experience those outcomes targeted by the intervention.Objective
To extrapolate a treatment effect similar to those reported in major randomized clinical trials of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for prevention of end-stage renal disease (ESRD) to a real-world population of older patients with chronic kidney disease.Design, setting, and participants
Simulation study in a retrospective cohort conducted in Department of Veterans Affairs medical centers. We included 371
SUBMITTER: O'Hare AM
PROVIDER: S-EPMC4119007 | biostudies-literature | 2014 Mar
REPOSITORIES: biostudies-literature